Home > Healthcare > Analytical Instruments > Molecular Analysis > In-situ Hybridization Market

In-situ Hybridization Market Share

Report ID: GMI3991
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

In-situ Hybridization Market Share

The in-situ hybridization industry is highly competitive, marked by several players striving for market dominance. Providers offer comprehensive in-situ hybridization for biomarker discovery target therapy, and accurate diagnostics. This includes innovations such as automated ISH platforms and robotic systems for workflow efficiency, reducing hands-on time, and reproducibility. Competition is driven by factors such as the quality and reliability of these technologies, integration capabilities with existing platforms, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.

In-situ Hybridization Market Companies

Some of the eminent market participants operating in the in-situ hybridization industry include:

Agilent Technologies, Inc.
Bio-Techne Corporation
Bio-Rad Laboratories, Inc.
Bio View Ltd.
Danaher Corporation
Merck KGaA
Neogenomics, Inc.
PerkinElmer, Inc.
Sysmex Corporation
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of in-situ hybridization reached USD 1.6 billion in 2023 and is set to witness 8.6% CAGR from 2024 to 2032, owing to growing prevalence of chronic diseases, R&D investments, and rising adoption of genetic testing.

Fluorescent in-situ hybridization segment size reached USD 888.8 million in 2023, as it allows for easy visualization and imaging of DNA or RNA targets under a fluorescence microscope.

The U.S. market size is anticipated to grow at 8.2% CAGR during 2024-2032, attributed to the technological advancements in in-situ hybridization.

Agilent Technologies, Inc., Bio-Techne Corporation, Bio-Rad Laboratories, Inc., Bio View Ltd., Danaher Corporation, Merck KGaA, Neogenomics, Inc., PerkinElmer, Inc., Sysmex Corporation and Thermo Fisher Scientific Inc.